Your session is about to expire
← Back to Search
Advanced MRI Imaging for Kidney Cancer
Study Summary
This trial uses advanced imaging to assess if a kidney tumor is cancerous and how it may affect kidney function after surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this clinical study accept participants over the age of 35?
"The requirements for entering this medical trial specify that participants must be between 21 to 85 years old. There are 30 studies available for those younger than 18 and 426 trials catering to the elderly population over 65."
Who qualifies to participate in this medical trial?
"The criteria for entry into this trial necessitates that kidney cancer patients aged 21 to 85 years be selected. In total, 150 participants may take part in the study."
How many individuals can enroll in this clinical trial at maximum capacity?
"Affirmative. The information hosted on clinicaltrials.gov asserts that, as of October 31st 2023, this medical trial is actively recruiting participants. It was initially published in December 1st 2022 and requires 150 patients from a single location to complete the study."
Is participation in this clinical research still an option for those who qualify?
"Affirmative. According to clinicaltrials.gov, this medicinal trial is still gathering participants since its initial post date of December 1st 2022 and most recent update on October 31st 2023. To complete the study, 150 people need to be enrolled at one medical clinic."
Share this study with friends
Copy Link
Messenger